Increasing patient access to faecal microbiota transplantation with remote delivery: a cost analysis of outpatient versus home-based treatment
Capsule-based FMT treatment has made it clinically and economically feasible to administer FMT in contextual settings outside of specialised hospitals. Our findings highlight the importance of local hospital-based treatment for increasing patient access to FMT, the ability to ship FMT to remote locations lacking a FMT centre, and the option of home-based treatment for a selected group of patients who may not tolerate transport to hospital.
Authors
- Tone Rubak (ORCID: https://orcid.org/0000-0003-4496-391X)
- Christian Lodberg Hvas (ORCID: https://orcid.org/0000-0001-7973-7184)
- Rasmus H. Olesen
- Simon Mark Dahl Baunwall (ORCID: https://orcid.org/0000-0002-5135-7435)
- Jens Frederik Dahlerup (ORCID: https://orcid.org/0000-0002-1587-7636)
- Lars Holger Ehlers (ORCID: https://orcid.org/0000-0001-6512-5566)
- Merete Gregersen (ORCID: https://orcid.org/0000-0002-5365-7335)
- Trine Kjær (ORCID: https://orcid.org/0000-0002-9554-374X)
- Christian Erikstrup (ORCID: https://orcid.org/0000-0001-6551-6647)
- K. J. Olsen
- Sara Ellegaard Paaske (ORCID: https://orcid.org/0009-0006-7469-9995)
- C Krogh
- Emma Bendix Larsen (ORCID: https://orcid.org/0000-0002-9317-4194)
Institutions
- University of the Faroe Islands (FO)
- Aarhus University (DK)
- Aarhus University Hospital (DK)
Publication Details
- Journal
- Health Economics Review
- Published
- 2025-11-24
- DOI
- https://doi.org/10.1186/s13561-025-00706-8
- Primary Topic
- Clostridium difficile and Clostridium perfringens research
- Type
- article
- Field-Weighted Citation Impact
- 0.00